Speaker illustration

Professor Denis Xavier

St John's Medical College Hospital, Bangalore (India)

Patients with atrial fibrillation treated with apixaban are less likely to discontinue study drug when compared with warfarin: insights from the ARISTOTLE trial

Event: ESC Congress 2016

Topic: Atrial fibrillation (AF)

Session: Anticoagulation in atrial fibrillation III

Thumbnail